Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review

Prostate International - Tập 10 - Trang 117-122 - 2022
Sachin Perera1,2, Jodie McDonald1,3, Isabella Williams1, Jonathan O'Brien3, Declan Murphy3, Nathan Lawrentschuk1,2
1Department of Urology and Department of Surgery, Royal Melbourne Hospital University of Melbourne, Australia
2EJ Whitten Foundation Prostate Cancer Research Centre at Epworth, Melbourne, Australia
3Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia

Tài liệu tham khảo

Willemse, 2022, Systematic Review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy, Eur Urol, 81, 337, 10.1016/j.eururo.2021.12.007

Cowan, 2020, Detection of clinically significant cancer in the anterior prostate by transperineal biopsy, BJU Int, 126, 33, 10.1111/bju.15124

Doan, 2021, A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?, BJU Int, 128, 36, 10.1111/bju.15554

Neal, 2020, Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protect randomised controlled trial according to treatment received, Eur Urol, 77, 320, 10.1016/j.eururo.2019.10.030

Wilt, 2012, Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, 367, 203, 10.1056/NEJMoa1113162

Hamdy, 2016, 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer, N Engl J Med, 375, 1415, 10.1056/NEJMoa1606220

Ong, 2022, Large variation in conservative management of low-risk prostate cancer in Australia and New Zealand, BJU Int, 130, 17, 10.1111/bju.15698

Mahal, 2019, Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015, JAMA, 321, 704, 10.1001/jama.2018.19941

Lawrentschuk, 2022, Sensible government decisions on funding for imaging can change practice and deliver better care for men with prostate cancer, BJU Int, 130, 4, 10.1111/bju.15815

Shore, 2022, Active surveillance plus enzalutamide monotherapy vs active surveillance alone in patients with low-risk or intermediate-risk localized prostate cancer: the ENACT randomized clinical trial, JAMA Oncol, 8, 1128, 10.1001/jamaoncol.2022.1641

McLeod, 2006, Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer, BJU Int, 97, 247, 10.1111/j.1464-410X.2005.06051.x

Fleshner, 2012, Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial, Lancet, 379, 1103, 10.1016/S0140-6736(11)61619-X

Andriole, 2010, Effect of dutasteride on the risk of prostate cancer, N Engl J Med, 362, 1192, 10.1056/NEJMoa0908127

Gill, 2018, Randomized trial of partial gland ablation with vascular targeted phototherapy versus active surveillance for low risk prostate cancer: extended followup and analyses of effectiveness, J Urol, 200, 786

Trottier, 2010, Nutraceuticals and prostate cancer prevention: a current review, Nat Rev Urol, 7, 21, 10.1038/nrurol.2009.234

Jarrard, 2021, A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance, Prostate, 81, 41, 10.1002/pros.24076

Shahvazi, 2019, The effect of vitamin D supplementation on prostate cancer: a systematic review and meta-analysis of clinical trials, Horm Metab Res, 51, 11, 10.1055/a-0774-8809

Parsons, 2018, A randomized, double-blind, phase II trial of PSA-TRICOM (PROSTVAC) in patients with localized prostate cancer: the immunotherapy to prevent progression on active surveillance study, Eur Urol Focus, 4, 636, 10.1016/j.euf.2018.08.016

Kang, 2019, Exercise during active surveillance for prostate cancer-the ERASE trial: a study protocol of a phase II randomised controlled trial, BMJ Open, 9, 10.1136/bmjopen-2018-026438

Papadopoulos, 2021, High-intensity interval training or resistance training versus usual care in men with prostate cancer on active surveillance: a 3-arm feasibility randomized controlled trial, Appl Physiol Nutr Metabol, 46, 1535, 10.1139/apnm-2021-0365

Brassetti, 2021, Physical activity decreases the risk of cancer reclassification in patients on active surveillance: a multicenter retrospective study, Prostate Cancer Prostatic Dis, 24, 1151, 10.1038/s41391-021-00375-8

Thông tin
Thông tin xuất bản

Prostate International

Tập 10

117-122

Thông tin tác giả